A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease
- 1 August 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 6 (8) , 437-442
- https://doi.org/10.1097/00006231-198508000-00002
Abstract
The first clinical data is given on 99Tcm-hexamethylpropyleneamine oxime (HM-PAO) in normal subjects and patients with established stroke. Regional cerebral blood flow maps (rCBF) have been recorded and displayed in tomographic mode with this new radiopharmaceutical. Good images were obtained, comparable to those achieved with 123I-isopropylamphetamine (IMP).Keywords
This publication has 0 references indexed in Scilit: